US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist

19.720
-0.260-1.30%

Trading Mar 28 14:58 ET

1.31BMarket Cap-8.05P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 1.230M	--
--	2025/Q1	-- / 1.079M	--
--	2024/Q4	1.175M / 1.252M	--
--	2024/Q3	3.191M / 1.074M	--
--	2024/Q2	2.498M / 854.290K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 1.230M--

--2025/Q1-- / 1.079M--

--2024/Q41.175M / 1.252M--

--2024/Q33.191M / 1.074M--

--2024/Q22.498M / 854.290K--

Unlock Free Earnings Estimates

Open Account

Celldex Therapeutics Earnings Reports

Celldex Therapeutics | 10-K: FY2024 Annual Report

Feb 27 16:06 ET

Celldex Therapeutics | 8-K: Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Feb 27 16:01 ET

Celldex Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:07 ET

Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6, 2024 16:02 ET